Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yishen Shujin Decoction for Fibromyalgia Syndrome
NCT07555691Recruiting
- Start
- Mar 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in fibromyalgia (FM) comparing Placebo Group with YishenShujin Decoction Group (2 arms). Primary endpoint: Brief Pain Inventory at 24 weeks. Started Mar 2025; status: recruiting.
02
Drugs
Yishen Shujin Decoction
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07555691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07555691.